Hey Bottle,
Not quite correct. The comparable quarter (to current) had revenue of $6.1M. This has nothing to do with the R&D rebate. The rebate boosts cash received in the quarter and minimises cash outflows, but is not part of the revenue figure. I have this quarter at a 30% increase on the previous, which is only a 9% increase on PCP. ( I think and hope that this may prove to be a conservative estimate).
My thoughts on AHZ, page-174
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.80 | 10 | 2 |
View Market Depth
| Last trade - 16.16pm 22/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable